Intravitreal Ranibizumab Treatment in Macular Edema Secondary to Central Retinal Vein Occlusion
ÖZKAYA, Abdullah, BAZ, Ökkeş, TARAKÇIOĞLU, Hatice Nur
Abstract
ÖZKAYA, Abdullah, BAZ, Ökkeş, TARAKÇIOĞLU, Hatice Nur
Abstract
The two main complications of central retinal vein occlusion are macular edema and neovascularizations. Intravitreal anti-vascular growth factor and corticosteroid injections are the mainstays of the current treatment of central retinal vein occlusion. In this review, we aimed to summarize the clinical studies of intravitreal ranibizumab in macular edema secondary to central retinal vein occlusion.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The two main complications of central retinal vein occlusion are macular edema and neovascularizations. Intravitreal anti-vascular growth factor and corticosteroid injections are the mainstays of the current treatment of central retinal vein occlusion. In this review, we aimed to summarize the clinical studies of intravitreal ranibizumab in macular edema secondary to central retinal vein occlusion.
Key concepts: Ranibizumab, Medicine, Central retinal vein occlusion, Macular edema, Retinal Vein, Ophthalmology, Occlusion, Retinal